Hypoactive sexual desire disorder
| Hypoactive Sexual Desire Disorder | |
|---|---|
| Synonyms | HSDD |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Low sexual desire, lack of sexual thoughts or fantasies |
| Complications | N/A |
| Onset | Can occur at any age |
| Duration | Persistent or recurrent |
| Types | N/A |
| Causes | Multifactorial, including biological, psychological, and social factors |
| Risks | Relationship issues, stress, hormonal changes |
| Diagnosis | Clinical assessment, DSM-5 criteria |
| Differential diagnosis | Depression, Anxiety disorders, Hypogonadism |
| Prevention | N/A |
| Treatment | Psychotherapy, Sex therapy, Hormone therapy, Flibanserin |
| Medication | Flibanserin, Bremelanotide |
| Prognosis | N/A |
| Frequency | Common, varies by population |
| Deaths | N/A |
Hypoactive Sexual Desire Disorder (HSDD) is a clinical condition characterized by a persistent or recurrent lack of sexual fantasies or desire for sexual activity. This condition is considered a sexual dysfunction and can cause significant distress or interpersonal difficulties for the individual affected.
Definition and Diagnosis[edit]
- HSDD is defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulties. Furthermore, the condition cannot be better explained by a non-sexual mental disorder, a consequence of severe relationship distress or other significant stressors, or attributable to the effects of a substance/medication or another medical condition[1].
- Diagnosis is typically made by a healthcare professional after a thorough medical and psychological examination, along with detailed inquiries about the individual's sexual and psychosocial history.
Causes and Risk Factors[edit]
- There are various potential causes and risk factors for HSDD, including both physical and psychological issues:
- Medical conditions such as diabetes, heart disease, or hormonal imbalances can impact sexual desire.
- Certain medications, including some antidepressants and contraceptives, can also decrease sexual desire.
- Psychological issues such as depression, anxiety, or past sexual trauma can contribute to HSDD.
- Relationship issues such as lack of emotional intimacy or unresolved conflict can also be associated with diminished sexual desire[2].
Treatment
- The treatment for HSDD typically involves a combination of medical treatment and psychotherapy:
- Medical treatment may include hormone therapy or FDA-approved medications like flibanserin for premenopausal women.
- Psychotherapy, such as cognitive-behavioral therapy (CBT), can be helpful in addressing underlying psychological issues or improving sexual communication with the partner[3]
Epidemiology[edit]
HSDD is a relatively common condition, with studies suggesting that it affects approximately 10% of adult women and is less prevalent among men. The prevalence increases with age and other risk factors[4].
Impact on Quality of Life[edit]
HSDD can have a significant impact on an individual's quality of life, affecting self-esteem, body image, and intimate relationships. The distress caused by this condition extends beyond the sexual realm, influencing overall mental health and well-being[5].
See also[edit]
- Sexual dysfunction
- Flibanserin
- Cognitive behavioral therapy
- Diagnostic and Statistical Manual of Mental Disorders
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
